Exodus Point Capital Management, LP Abb Vie Inc. Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 1,600 shares of ABBV stock, worth $280,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,600

Previous 23,700 93.25%

Holding current value

$280,608

Previous $4.07 Million 92.23%

% of portfolio

0.0%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $6.14 Million - $7.47 Million	37,472 New	37,472 $7.4 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $12.4 Million - $14.4 Million	-92,885 Reduced 28.75%	230,193 $34.3 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $26.9 Million - $33.5 Million	202,892 Added 168.82%	323,078 $43.5 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $17.1 Million - $19.7 Million	118,218 Added 6007.01%	120,186 $19.2 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $272,194 - $326,432	1,968 New	1,968 $318,000
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $5.76 Million - $6.61 Million	-42,941 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$137.62 - $174.96 $2.86 Million - $3.64 Million	20,795 Added 93.9%	42,941 $6.58 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $2.92 Million - $3.63 Million	22,146 New	22,146 $3.59 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $8.38 Million - $10.6 Million	-77,978 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $4.85 Million - $5.51 Million	45,610 Added 140.91%	77,978 $8.41 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $6.55 Million - $7.29 Million	-62,225 Reduced 65.78%	32,368 $3.65 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1.42 Million - $1.56 Million	13,865 Added 17.17%	94,593 $10.2 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $4.76 Million - $6.43 Million	59,192 Added 274.85%	80,728 $8.65 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $617,864 - $725,169	-7,192 Reduced 25.03%	21,536 $1.89 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $2.11 Million - $2.82 Million	28,728 New	28,728 $2.82 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $1.74 Million - $2.64 Million	-26,984 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $716,683 - $896,724	-9,936 Reduced 26.91%	26,984 $2.39 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $1.64 Million - $1.97 Million	26,008 Added 238.34%	36,920 $2.8 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $716,918 - $916,389	10,912 New	10,912 $794,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Abb Vie Inc. Transaction History